Medical device correction: FreeStyle Libre 3 (Abbott – December)

Dec. 2025Pharmacy Updates

Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.

The sensors are being corrected because some may give incorrect low glucose readings. Individuals with diabetes who get false low readings may make unsafe treatment decisions, such as such as excessive carbohydrate intake or skipping insulin doses. This can pose serious health risks, including injury or death.

The groups below are part of the correction.

  • FreeStyle Libre 3 Sensor
    • Model numbers: 72081-01, 72080-01
    • Unique device identifiers (UDI-DIs): 00357599818005 and 00357599819002
  • FreeStyle Libre 3 Plus Sensor
    • Model numbers: 78768-01, 78769-01
    • UDI-DIs: 00357599844011 and 00357599843014

If a patient’s device’s model number or UDI-DI is listed above, they should visit FreeStyleCheck.com and enter their sensor serial number to learn if their device is affected by the correction. The website explains how to find the serial number.

The FDA recommends that patients with affected sensors stop using them immediately and throw them away. They should then enter their contact information on the website so Abbott can send them a replacement sensor at no cost.

Abbott suggests that those with signs of low glucose or who think their glucose reading is wrong use any glucometer to do a fingerstick test. This includes the built-in blood glucose meter in the FreeStyle Libre 3 reader.

As of Nov. 14, Abbott had reported 736 serious injuries and 7 deaths associated with this issue. The FDA is reviewing this potentially high-risk device issue and will keep the public informed as new information becomes available.

To learn more about this recall, your patients can take one or more of the steps below.

  • Talk to your or their pharmacist.
  • Call Abbott at 1-833-815-4273. Help is available seven days a week from 8 a.m. to 8 p.m. ET.
  • Visit the FDA website.

Recent Announcements

Virtual Institute: Bridging the Gap: Foundations of Integrated Care CME Courses Available

Bridging the Gap: Foundations of Integrated Healthcare is a free educational series designed to support behavioral health and physical health providers in integrating physical health and wellness strategies into their practices and programs to support recovery of individuals living with serious mental illnesses. The series emphasizes tools, education, and resources that empower healthcare providers and individuals to become informed and effective managers of their health and health care.
Jun. 2026Education/Webinars

Important information regarding Medicare GLP-1 Bridge through CMS

The Centers for Medicare & Medicaid Services (CMS) is expanding access to certain GLP-1 medications through the Medicare GLP-1 Bridge short-term demonstration starting July 1, 2026.
Jun. 2026Important Notices

CME/CEU Webinar: Bright Beginnings: The Role of Medical and Dental Providers in Early Oral Health

Please join us for a live, CME-accredited and CEU-accredited webinar on Monday, Aug. 24 from noon to 1 p.m., that will educate providers on the importance of early childhood oral health.
Jun. 2026Education/Webinars